Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
Experimental drug halves cholesterol levels in phase 2 clinical trials
Scientists are reporting promising results from a phase 2 clinical trial of a cholesterol-reducing drug called evinacumab.
Buffett's Berkshire bets big on AbbVie, Bristol Myers, Merck, Pfizer as COVID-19 drives healthcare investment
As the COVID-19 pandemic fuels a global interest in healthcare, many deep-pocketed investors have diverted their money to the sector.
Arthritis drug may improve Covid-19 survival among elderly patients, says study
A drug used to treat rheumatoid arthritis may reduce the risk of dying for elderly patients with Covid-19, and provide a new weapon in the arsenal against the novel coronavirus, according to a study.
AZ’s Brilinta reduced rate of stroke and death in high-risk subgroup
AstraZeneca’s P2Y12 receptor antagonist Brilinta reduced the rate of stroke and death in a prespecified, high-risk subgroup, according to new analysis of the phase III THALES trial.
ViiV’s cabotegravir scores breakthrough designation for HIV prevention
GlaxoSmithKline subsidiary ViiV Healthcare has announced that its long-acting injectable cabotegravir has scored a breakthrough therapy designation (BTD) from the US Food and Drug Administrati...
Hospitals around the US are panic buying hyper-cold freezers in anticipation of Pfizer's coronavirus vaccine
States and hospital systems across the US have started panic-buying ultra low temperature freezers capable of storing Pfizer's coronavirus vaccine.
Samsung BioLogics says mass producing Eli Lilly's COVID-19 treatment
SEOUL (Reuters) - Samsung BioLogics Co Ltd on Tuesday said it is mass-producing a COVID-19 antibody treatment developed by Eli Lilly and Co, as the United States began distributing the drug la...
Mouthwash can kill coronavirus within 30 seconds: Research
Cardiff University researchers found that mouthwash emanating from the mouth contained 0.
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2020
Five new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended five medicines for approval at its November 2020 meeting.
Diabetes Drug Can Treat and Reverse Heart Failure and Reduce Hospitalizations
Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine ...
Moderna says its coronavirus vaccine is nearly 95% effective
Moderna said Monday that its coronavirus vaccine candidate is 94.
Antidepressant fluvoxamine may help prevent Covid-19 severity
Researchers at the Washington University School of Medicine carried out a study that suggested antidepressant drug fluvoxamine could be effective in the prevention of severe Covid-19 cases that lead t...
7
8
9
10
11
12
13
14
15
